Indications for Renal Biopsy

Core Indications for Renal Biopsy

The American Society of Nephrology recommends renal biopsy for patients with nephrotic syndrome, nephritic syndrome, and rapidly progressive acute renal failure of unknown origin, as early diagnosis can prevent irreversible kidney damage 1
The National Kidney Foundation suggests that renal biopsy is essential for patients with unexplained proteinuria, as histologic confirmation is necessary for diagnosis and treatment planning 2
The European Renal Association recommends biopsy for patients with renal disease in the context of systemic disorders, such as lupus, vasculitis, or monoclonal gammopathy, to distinguish disease-related kidney involvement from unrelated pathology 3

The International Society of Nephrology recommends that patients with monoclonal gammopathy and renal manifestations undergo thorough evaluation with biopsy, as MGUS is uncommon in patients under 50 years 3
The American College of Rheumatology suggests that biopsy is strongly supportive for patients with ANCA-associated vasculitis, but treatment should not be delayed awaiting histological confirmation if clinical presentation and serology are typical 4
The American Society of Transplantation recommends biopsy for patients with renal transplant dysfunction, as imaging cannot distinguish rejection from other causes, and biopsy results alter management in approximately 40% of cases 5

The American Society of Nephrology reports that major complications requiring intervention occur in only 0.032-0.7% of renal biopsy cases, and death directly related to biopsy is extremely rare (0.009-0.33% of cases) 6
The National Kidney Foundation recommends limiting needle passes to 4 or fewer to minimize bleeding risk, and ensuring normal bleeding and partial thromboplastin times prior to the procedure 6

The College of American Pathologists recommends that at least 8-10 glomeruli are needed for light microscopy to diagnose or exclude specific histopathologic patterns with reasonable confidence 1
The International Society of Nephrology suggests that immunohistology is required to detect immunoreactants, and electron microscopy is essential to define location and characteristics of immune deposits 1